March 5, 2019 / 12:08 PM / in a year

BUZZ-Cowen starts Aurora Cannabis with 'outperform', Cronos on 'market-perform'

** U.S.-listed shares of Aurora Cannabis Inc up 3.2 pct at $7.45

** Cowen & Co starts covering ACB’s Canadian listing with an “outperform” rating and a C$14 price target, 45.8 pct above its Monday closing price

** ACB is well positioned to benefit in the early innings of the Canadian adult use market, given its impressive 20 pct market share to date - Cowen

** Avg. rating on ACB, out of the 10 analysts covering its stock is “buy” with median PT is C$14

** Cowen starts covering Cronos Group Inc with a “market perform” rating and a C$29 PT, says it likes “CRON’s story as an asset-light, global low-cost producer”

** Of the 8 analysts covering CRON, mean rating on the stock is “hold” and median PT is C$19.50

** CRON’s U.S.-listed shares had not changed hands before the bell

** Up to Monday’s close, U.S.-listed ACB shares had jumped 45.6 pct this year, while those of Cronos had more than doubled (Reporting by Aaron Saldanha in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below